Iron deficiency in heart failure: screening, prevalence, incidence and outcome Data from the Swedish Heart Failure registry and the Stockholm CREAtinine Measurements collaborative project.

ID screening improved over time but is still limitedly implemented, despite being highly prevalent and incident, and independently associated with CV death or repeated HF hospitalizations regardless of EF. Most patients with ID had an iron need necessitating either repeated administrations of intravenous iron or a preparation permitting >1000 mg doses. These data highlight the need for improved screening for ID in HF. This article is protected by copyright. All rights reserved.